Precision and personalized medicine: deals decreased significantly in clinical trials in H2 2021
Deals relating to precision and personalized medicine have seen a decrease of 54.1% from H2 2020 to H2 2021.
By
2022 So far In Venture Capital
Latest in
2022 So far In Venture Capital
Robotics: Deals increase in clinical trial operations in H2 2021
Deals relating to robotics in the clinical trial operations sector have seen an increase of 500% from H2 2020 to…
By
CRO M&A deals reach new record, but what does this mean for clinical trial sponsors?
While CRO M&A diversifies a clinical trial service provider’s offering, it could also risk of a changing work culture.
By
Digitisation: deals drop significantly in clinical trial operations in H2 2021
This marks a deceleration in growth from the 54.5% decrease in deals that occurred in H1 2021 relative to the…
By
Revealed: countries with most M&A deals in the pharma industry
Globally, the situation is looking distinctly positive for mergers and acquisitions in the pharma industry.
By
Healthtech related deals in the clinical trial operations industry decreased in H1 2021
Healthtech related deals made up 15.4% of all deals announced in the clinical trial operations sector in the first six…
By
AI-related deals in the clinical trial operations industry decreased in H1 2021
AI-related deals made up 3.7% of all deals announced in the clinical trial operations sector.
By
Indian pharma deals landscape shaped by Covid-19
The number of deals made in the Indian pharma market increased by 22% from 2019 to 2020, likely due to…
By